XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Segment and Related Information (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Revenue and Operating Income (Loss)
Segment revenue and operating income (loss) were as follows during the periods presented:
(in millions)DiagnosticsOtherTotal
Three months ended March 31, 2021
Revenues$157.8 $15.3 $173.1 
Depreciation and amortization17.0 1.4 18.4 
Segment operating income (loss)10.5 (57.2)(46.7)
Three months ended March 31, 2020
Revenues$150.5 $13.5 $164.0 
Depreciation and amortization16.8 1.1 17.9 
Segment operating loss(93.6)(40.1)(133.7)

Three Months Ended
March 31,
(in millions)20212020
Total operating loss for reportable segments$(46.7)$(133.7)
Unallocated amounts:
Interest income0.2 0.8 
Interest expense(3.0)(2.3)
Other(0.1)4.1 
Loss from operations before income taxes(49.6)(131.1)
Income tax benefit(10.1)(15.9)
Net loss(39.5)(115.2)
Net loss attributable to non-controlling interest— — 
Net loss attributable to Myriad Genetics, Inc. stockholders$(39.5)$(115.2)